Actym Therapeutics

Developer of immunotherapy solutions for cancer and other serious diseases

placeBerkeley, California, United States calendar_todayFounded 2017 groups50 employees language actymthera.com

Registered entities

Investor mix

6 investors on record; lead investors include Boehringer Ingelheim Venture Fund, Panacea Venture, Illumina Ventures.

Investor typeCountShare
Venture capital583%
Bank & private debt117%
Coming soon